Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.
Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic. The company, which reported more than $100 billion in revenue in 2022 due to the lift from Covid-19 vaccine and therapeutic sales, sees 2024 revenues of between $58.5 billion and $61.5 billion, […]
The post Pfizer shares tumble on disappointing 2024 profit outlook appeared first on Insider Paper.
https://insiderpaper.com/pfizer-shares-tumble-on-disappointing-2024-profit-outlook/
Comments
0 comment